Health News Releases

  • Today June 9
December 14, 2022 15:40
Cancellation of remaining publicly held registered shares of Vifor Pharma AG
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (“Vifor”) announced today that the Commercial Court St. Gallen has cancelled (kraftlos erklärt) all remaining publicly
December 14, 2022 14:25
European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
The European Commission (EC) granted a conditional marketing authorization for Boehringer Ingelheim’s spesolimab as first in class treatment for GPP flares in adults.[1] Spesolimab is a novel, selecti
December 14, 2022 10:00
AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting
AOP Health announced its latest updates on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from AOP Health´s CONTINUATION-PV study (Reference Kiladjian et al. ASH 2022) and the LOW-PV
December 13, 2022 17:14
MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics—today announced that its Type-2 Diabetes Program, developed in collab
December 13, 2022 14:00
Masimo Announces Limited Market Release of Sepsis Index
Masimo (NASDAQ: MASI) today announced the limited market release of Sepsis Index (Si™), an early warning indicator designed to help clinicians identify possible sepsis in patients remotely monitored w
December 13, 2022 11:30
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
Organon (NYSE: OGN), a global women’s healthcare company, today announced that Kirke Weaver has been appointed General Counsel and Corporate Secretary, and will continue as a member of Organon’s execu
December 13, 2022 10:52
GI CELL Enters Agreement with Optieum Biotechnologies
GI CELL, Inc. announced that it has entered into a research license and option agreement with Optieum Biotechnologies, Inc. (Japan). Under the agreement, Optieum Biotechnologies will provide GI CE
December 12, 2022 15:15
Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
Takeda (TSE:4502/NYSE:TAK) today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology (ASH) Annual Meeting being held December 10-13, 2022 in New Or
December 12, 2022 10:00
Takeda’s QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted marketing authorization for the company’s dengue vaccine QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (T
December 09, 2022 14:32
ImmuneOncia Announces Phase 2 Results of PD-L1 Immune Checkpoint Inhibitor
ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 2 NK/T-cell lymphoma clinical trial of IMC-001, a PD-L1 monoclonal antibody, at the Asian Congress of the European Society for Medica
Eric Y. Kim, Principal Machine Learning Engineer of Bertis Bioscience
December 09, 2022 10:37
Bertis Reveals Research Results of AI-based Diagnosis Model with Proteomic Mass Spectrometry Data
Bertis, a proteomics-based precision medicine technology development company (CEOs Dong-young Noh, Seung-man Han), announced research results of AI-based disease diagnosis model, on December 8, 2022,
Ajoy Karna, CFO, Covetrus
December 09, 2022 09:30
Covetrus Names Ajoy Karna as Chief Financial Officer
Covetrus®, a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Fouls
Michael Prosser, Chief Business Officer, Crown Bioscience
December 09, 2022 09:15
Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
Crown Bioscience, Inc, a JSR Life Sciences Company, and ERS Genomics Limited (‘ERS’) have signed a global license agreement for access to the foundational CRISPR/Cas9 patent portfolio held by ERS, whi
December 09, 2022 09:00
PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the first immunological results of its PDC-LUNG-101
December 08, 2022 10:20
Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience
Medidata, a Dassault Systèmes company, launched a new patient-centric native myMedidata app, designed to provide trial participants with another option for a seamless platform experience and a single
December 08, 2022 09:40
Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes
The DINAMO Phase III clinical trial met its primary endpoint by demonstrating a statistically significant reduction in HbA1c (a marker of average blood sugar) with empagliflozin compared with placebo
December 07, 2022 14:50
Affiliates of ZCG Acquire Universal Marine Medical Supply International
Z Capital Partners, L.L.C., the private equity fund management arm of Z Capital Group, L.L.C. (“ZCG”), a leading privately held merchant bank, today announced that affiliates of ZCG have acquired Univ
December 05, 2022 09:40
Deadline for Aster Guardians Global Nursing Award 2023 worth US $250,000 extended until 12th December
Aster Guardians Global Nursing Award, an initiative by leading healthcare provider Aster DM Healthcare to recognize the contribution of nurses to the community, has announced an extension of deadline
December 02, 2022 15:25
New Crown Bioscience Publication Details Application of In Vitro 3D Organoids with Matched PDX for Clinically Relevant Oncology Drug Development
Crown Bioscience, a JSR Life Sciences company and Contract Research Organization (CRO), has announced the publication of its review paper entitled: Translational and Clinical Relevance of PDX-Derived
December 02, 2022 14:55
Sermo Survey Finds Opportunity to Educate General Care Physicians on PrEP to Increase Patient Adoption Nearly Half of General Care Physicians Reported They Do Not Have Enough Knowledge About PrEP Options to Discuss with Patients
Timed to World AIDS Day, Sermo, a physician-first online community and leader in global HCP insights, released a new survey that found 46% of general care physicians including PCPs, OB-GYNs, and pedia
December 02, 2022 09:20
Ferring Receives U.S. FDA Approval for REBYOTA® (fecal microbiota, live-jslm) - A Novel First-in-Class Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved REBYOTA® (fecal microbiota, live-jslm), a novel first-in-class microbiota-based live biotherapeutic indicat
December 01, 2022 09:50
AGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH
AGIC Capital (“AGIC”), a growth-oriented private equity firm with $2.2 billion of assets under management, today announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH (“ATEC” or “
December 01, 2022 09:50
ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced approval by the US Food and Drug Administration (FDA) of the IND application for a clinical trial evaluating Nanth
December 01, 2022 09:40
New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery
Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the st
December 01, 2022 09:40
ViiV Healthcare Unveils a New Global Study Revealing Three Quarters of People Believe There Are Still Negative Perceptions When It Comes to People Living With HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from a perceptions survey which unveils a widespread gap in
November 30, 2022 10:20
Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) will manufacture and supply intermediates to Shionogi & Co., Ltd. (Headquarters: Chuo-ku, Osaka; Chief Executive Officer:
November 30, 2022 10:10
Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to inves
November 29, 2022 13:20
LevitasBio Strengthens its C-Suite
LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of Global
November 28, 2022 16:05
Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients
Regulatory News: CSL Vifor and Fresenius Kabi today announced that China’s National Medical Products Administration (NMPA) has approved Ferinject®, a preparation for intravenous iron therapy for th
November 28, 2022 14:00
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant A
November 25, 2022 15:35
Iron Deficiency Day 2022: CSL Vifor calls to take iron seriously
Regulatory News: Tomorrow is Iron Deficiency Day. For the eighth consecutive year, CSL Vifor is supporting a growing alliance of international organizations including the Heart Failure Policy Netwo
November 23, 2022 16:50
Takeda’s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of the Biologics License Application (BLA) for TAK-003, the company
November 22, 2022 13:45
Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More Medicines to Patients Faster
Merck, a leading science and technology company, today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity. To achieve the goal of introduc
November 21, 2022 16:10
DentalMonitoring Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology
DentalMonitoring SAS, the inventor of the world’s first AI-driven remote monitoring and analysis solution for orthodontics, today announced that it has filed a patent infringement lawsuit against Alig
November 21, 2022 13:45
Monrol and FutureChem Announced a Clinical Supply Partnership
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) is delighted to announce that it has reached an agreement in principal with FutureChem based in Seoul, South Korea, a radiopharmaceutical company, for t
November 21, 2022 11:55
Phase 3 Trial of ICLUSIG® (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US
Takeda (TSE:4502/NYSE:TAK) today announced that the randomized, Phase 3 PhALLCON trial met its primary endpoint, demonstrating that adult patients with newly-diagnosed Philadelphia chromosome-positive
DEXLEVO at AMWC JAPAN: a Successful Debut
November 21, 2022 09:45
DEXLEVO at AMWC JAPAN: a Successful Debut
DEXLEVO, a company specializing in beauty medical devices, attended the Aesthetic and Anti-Aging Medicine World Congress (AMWC Japan) held for the first time in Japan. AMWC is one of the world’s three
November 18, 2022 16:40
The New England Journal of Medicine and NEJM Group partner with Wolters Kluwer to expand global reach of leading journals
Wolters Kluwer Health and NEJM Group have entered into an exclusive partnership to ensure that more researchers and clinicians around the world can access the growing family of NEJM Group journals. Bu
November 18, 2022 16:20
ImmunoMet Therapeutics Announces First Patient Dosed in a Phase 1b Trial of IM156 in Pancreatic Cancer
ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-cancer and anti-fibrotic therapies, today announces that the first patient has been dose
November 18, 2022 15:30
Neuraptive Therapeutics, Inc. Announces Appointment of Leading Industry Executive, Dr. Robert R. Ruffolo as New Director to the Board
Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by nerve injuries,
GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity
November 18, 2022 14:30
GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesne
November 16, 2022 11:20
Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
Medidata, a Dassault Systèmes company, today announced plans to launch Rave Companion, an innovative, scalable, patent pending technology helping clinical trial sites save time and reduce errors in tr
The GICELL presents preclinical data of T.O.P. NK at SITC in Boston, MA, USA. (Photo provided by GIC
November 16, 2022 11:06
GICELL Proves Excellent Anti-tumor Efficacy in Various Solid Tumor-bearing Animal Model
GICELL announced the data from the preclinical studies on T.O.P. NK (Tumor targeting, Optimally Primed NK), an allogeneic NK cell therapy which had been presented at the Society for Immunotherapy of C
November 15, 2022 14:45
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea’s Leading Bone Densitometry Platform
MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced that its novel method for enhancing osteopo
November 15, 2022 12:08
TMD LAB Starts Joint Research on Shape-memory Polymer Materials with US NIST
TMD LAB (CEO Hak-Joon Sung) and the National Institute of Standards and Technology (NIST) under the U.S. Department of Commerce are starting joint research on the properties of SMP materials. TMD L
November 14, 2022 17:35
World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
Late in 2021, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s R
November 11, 2022 22:00
Ur24Technology Launches New and Unique ‘TrueClr’ External Catheter Line
Ur24Technology Inc., a privately held medical device company, has launched the TrueClr catheter product line - offering physicians, nurses and patients a choice that will eliminate catheter-associated
November 11, 2022 16:25
European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Infection And/or Disease That Are Refractory (With or Without Resistance) to One or More Prior Therapies
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) has granted Marketing Authorization for LIVTENCITYTM (maribavir) for the treatment of cytomegalovirus (CMV) infection and/o
November 11, 2022 15:40
Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
Kirin Holdings Company, Limited (Kirin Holdings) and Kao Corporation (Kao) will participate in the “Wakayama Health Promotion Study” cohort study[*1] led by Wakayama Medical University and compiled by
Top US board-certified plastic surgeons were invited to Moonlight Sylfirm X Global Symposium 2022, a
November 11, 2022 10:59
RF Micro-needling Device, Sylfirm X Recognized by Top US Aesthetic Dermatologists
VIOL Co., Ltd hosted the first global event called ‘Moonlight Sylfirm X Global Symposium 2022’ on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium invited renowned domestic aesthetic d
25 per page50 per page75 per page100 per page